The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: ARM Leads Rising Market But Tour Operators Down

Mon, 18th Jul 2016 07:32

LONDON (Alliance News) - Stocks in London were higher shortly after the open Monday, with ARM Holdings shares rocketing to the top of the FTSE 100 after the company confirmed it has agreed to be acquired by SoftBank Group for GBP24.3 billion.

The FTSE 100 was up 0.7%, or 43.20 points at 6,713.14. The FTSE 250 was 1.0% higher at 16,894.26, while the AIM All-Share was adding 0.2% at 725.49.

Shares in ARM were up 45% at 1,729.00 pence. The FTSE 100-listed group, which makes chips used in smartphones and other connected devices, said Japanese technology and telecommunications conglomerate SoftBank will pay 1,700.00p per share.

That represents a 43% premium to ARM's closing price on Friday of 1,188.73p and a 42% premium to the all-time high that ARM shares hit in March 2015. The agreement earlier had been reported by the Financial Times newspaper.

SoftBank said is intends to maintain ARM's existing management team and brand and will maintain the company's headquarters in Cambridge. It plans to at least double ARM's UK headcount over the next five years and will boost the group's employee numbers internationally too. ARM's board said it unanimously recommends the offer.

Accendo Markets analyst Michael van Dulken said the positive open comes after the Turkish government took back control after a failed military coup. However, the analyst said that "this happening so soon after the tragic events in Nice last week simply adds to plentiful pre-existing geopolitical tension".

Van Dulken said investors will focus on the potential consequences the events in Turkey for both Middle East and European stability given the country's strategic geographic location.

Travel stocks were mixed. Air carriers International Consolidated Airlines Group and easyJet up 2.2% and 1.0%, respectively. However, travel operator TUI Group was down 1.6% and FTSE 250-listed Thomas Cook Group was the biggest mid-cap decliner, down 5.4%.

Shares in FTSE 100-listed AstraZeneca were up 0.6%. The drugmaker said its Tagrisso lung cancer treatment met its primary endpoint in phase 3 trials. AstraZeneca said the drug demonstrated superior progression-free survival rates in comparison to standard platinum-based doublet chemotherapy.

British Land was down 0.4%. The commercial property investor said that, while too early to assess the impact the UK's vote to leave the European Union will have on property markets in the UK, it does anticipates some extra caution from occupiers and investors.

Due to this, Liberum kept a Sell recommendation on British Land, but the broker acknowledged that it was a "robust quarter" for the real estate group.

British Land said that, in the first quarter to the end of June, it secured 256,000 square feet of retail lettings and renewals. Retail footfall in its properties was flat in the quarter, it said. Office lettings and renewals in the quarter totalled 25,000 square feet. Its said its occupancy rate is at 99% and confirmed its dividend for the first quarter of 7.30 pence per share, 3.0% higher year-on-year.

Ahead in the economic calendar on Monday, Bank of England Monetary Policy Committee member Martin Weale is due to make a speech at 0915 BST, and the Bundesbank's monthly report is at 1100 BST. Later in the day is the US National Association of Home Builders' housing market index.

Already released, the average asking price of a house in the UK was down 0.9% in July from the month before, property tracking website Rightmove said on Monday - coming in at GBP307,824. That followed a 0.8% increase in June. On a yearly basis, prices advanced 4.5%, slowing from 5.5% in the previous month.

Meanwhile, British retailers logged the steepest decline in footfall since early 2014, data published by the British Retail Consortium and Springboard showed. In June, footfall dropped 2.8% in June from last year, following a 0.3% rise in May. This was the sharpest fall since February 2014.

In Asia on Monday, the Tokyo market was closed for the Marine Day holiday. In China, the Shanghai Composite index fell 0.4%, while the Hang Seng index in Hong Kong continues up 0.7%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.